ybiU Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
ybiU antibody; b0821 antibody; JW0805Uncharacterized protein YbiU antibody
Target Names
ybiU
Uniprot No.

Q&A

What is the ybiU protein and why is it significant for bacterial research?

The ybiU gene encodes an uncharacterized predicted protein in Escherichia coli that has recently gained research interest due to its potential role in stress responses. It has been implicated in low pH tolerance mechanisms, with ybiU up-regulation demonstrating significant growth advantages in acidic conditions . As an uncharacterized protein, ybiU represents an important research target for understanding novel bacterial adaptation mechanisms. When designing experiments to investigate ybiU function, researchers should consider incorporating pH-based stress conditions to observe potential phenotypic changes.

What validation strategies are essential before using ybiU Antibody in experiments?

Proper antibody validation is critical for ensuring reliable experimental results. For ybiU Antibody, validation should include:

  • Knockout validation: Testing the antibody against wild-type E. coli and isogenic ybiU knockout strains to confirm specificity

  • Western blot with recombinant protein: Using purified recombinant ybiU protein as a positive control to verify the correct molecular weight detection

  • Cross-reactivity assessment: Testing against closely related bacterial species to determine specificity boundaries

  • Application-specific validation: Confirming performance in your specific experimental context (Western blot, immunoprecipitation, or immunofluorescence)

Recent antibody characterization initiatives have emphasized that approximately 50% of commercial antibodies fail to meet basic standards for characterization, highlighting the importance of rigorous validation before experimental use .

What are the recommended protocols for using ybiU Antibody in Western blot applications?

When using ybiU Antibody for Western blot applications, researchers should consider the following protocol optimizations:

  • Sample preparation: Extract proteins under native or denaturing conditions depending on the epitope characteristics of the antibody

  • Blocking optimization: Test both BSA and non-fat dry milk blocking solutions to determine optimal signal-to-noise ratio

  • Antibody dilution series: Perform a titration series (typically 1:500 to 1:5000) to determine optimal concentration

  • Essential controls:

    • Include isogenic ybiU knockout strain lysate as a negative control

    • Use recombinant ybiU protein as a positive control

    • Consider testing under different growth conditions (pH 7 vs. pH 5) to assess expression differences

Research has demonstrated that knockout cell lines provide superior controls compared to other types of controls for Western blot applications .

How can immunoprecipitation protocols be optimized for ybiU protein interaction studies?

For successful immunoprecipitation of ybiU and its interaction partners:

  • Crosslinking considerations: Since ybiU is an uncharacterized protein, test both formaldehyde and DSP crosslinkers to preserve weak or transient interactions

  • Lysis buffer optimization: Begin with a standard RIPA buffer, but consider testing gentler NP-40 or digitonin-based buffers if interactions are not maintained

  • Antibody binding conditions: Optimize antibody-to-lysate ratio and incubation time/temperature

  • Washing stringency: Balance between removing non-specific binding and preserving specific interactions

  • Elution strategy: Consider both acid elution and competitive elution with peptides if available

For verifying ybiU interactions, mass spectrometry analysis of immunoprecipitated complexes can provide unbiased identification of potential binding partners .

How can ybiU Antibody be used to investigate the protein's role in bacterial stress response mechanisms?

To investigate ybiU's role in stress responses:

  • Stress condition panel: Examine ybiU expression levels across multiple stress conditions (acid, oxidative, osmotic, nutrient limitation) using Western blot with the validated antibody

  • Temporal dynamics: Perform time-course experiments to determine the kinetics of ybiU expression following stress exposure

  • Subcellular localization: Use cell fractionation followed by Western blot or immunofluorescence to determine if ybiU relocates within the cell during stress

  • Protein modification analysis: Investigate potential post-translational modifications under stress using 2D gel electrophoresis followed by Western blot

  • Protein-protein interactions: Compare immunoprecipitation results between normal and stress conditions to identify stress-specific interaction partners

Research has demonstrated that ybiU upregulation confers significant growth advantages at pH 5, suggesting a role in acid stress response mechanisms .

What approaches can resolve contradictory results when using ybiU Antibody in different experimental systems?

When facing contradictory results:

  • Antibody lot testing: Verify performance across different antibody lots, as significant lot-to-lot variation is a known issue with antibodies

  • Epitope mapping: Determine if the antibody recognizes a conformational or linear epitope, which may explain differential recognition under various experimental conditions

  • Protocol standardization: Implement consensus protocols developed through collaborative efforts like those from YCharOS

  • Multiple antibody validation: Use alternative antibodies targeting different epitopes of ybiU to confirm results

  • Orthogonal techniques: Complement antibody-based detection with orthogonal approaches such as mass spectrometry or RNA expression analysis

Recent studies have shown that even well-characterized antibodies can yield contradictory results under different experimental conditions, reinforcing the importance of comprehensive validation .

How can ybiU Antibody be used to investigate potential epistatic relationships with other bacterial genes?

Investigating epistatic relationships requires:

  • Combinatorial genetic background analysis: Use the antibody to measure ybiU expression across strains with various genetic backgrounds (wild-type, single mutants, double mutants)

  • Correlation analysis: Compare ybiU protein levels with phenotypic outcomes to establish causative relationships

  • Induction studies: Analyze how controlled expression of potential interacting genes affects ybiU levels

  • Protein complex mapping: Use serial immunoprecipitation to determine if ybiU participates in protein complexes with products of epistatically interacting genes

Research has identified a double mutant strain (ybiU up; ydfZ down) that demonstrates slightly positive epistasis with approximately 65% increased growth relative to wild type at pH 5, suggesting functional interaction between these genes .

What methodological approaches can help characterize the function of uncharacterized proteins like ybiU?

For uncharacterized proteins like ybiU:

  • Structural prediction and analysis: Use computational approaches to predict potential functional domains

  • Interactome mapping: Use immunoprecipitation with ybiU Antibody followed by mass spectrometry to identify interacting partners

  • Phenotypic profiling: Compare phenotypes of wild-type, knockout, and overexpression strains across diverse conditions

  • Evolutionary conservation analysis: Examine the conservation pattern of ybiU across bacterial species to infer functional importance

  • Metabolomic profiling: Compare metabolic profiles between wild-type and ybiU mutant strains to identify affected pathways

Table 2: Recommended Validation Approaches for ybiU Antibody

Validation MethodImplementation DetailsExpected Outcome
Knockout ControlTest against wild-type and ΔybiU E. coliSignal present in wild-type, absent in knockout
Western Blot AnalysisSDS-PAGE separation followed by immunoblottingSingle band at predicted molecular weight
Overexpression ValidationTest against strain overexpressing ybiUIncreased signal intensity proportional to expression
ImmunofluorescenceFixed E. coli cells with fluorescent secondary antibodySpecific subcellular localization pattern
Mass Spectrometry ValidationImmunoprecipitation followed by MS identificationConfirmation of ybiU in pulled-down fraction

How can researchers address non-specific binding when using ybiU Antibody in immunoblotting applications?

Non-specific binding can be addressed through:

  • Blocking optimization: Test different blocking agents (BSA, milk, commercial blockers) and concentrations

  • Antibody dilution adjustment: Increase dilution to reduce non-specific binding while maintaining specific signal

  • Washing optimization: Increase detergent concentration (0.1-0.5% Tween-20) or washing duration

  • Pre-adsorption: Pre-incubate antibody with knockout cell lysate to reduce non-specific binding

  • Secondary antibody controls: Include secondary-only controls to identify background from secondary antibody

Research has shown that approximately 12 publications per protein target include data from antibodies that fail to recognize the relevant target protein, highlighting the importance of proper controls and optimization .

What methodological adaptations are needed when studying ybiU expression under different physiological conditions?

When studying condition-dependent expression:

  • Extraction buffer modification: Adapt protein extraction methods to ensure consistent recovery across different physiological states

  • Loading control selection: Choose loading controls that remain stable under the studied conditions

  • Signal normalization: Implement quantitative Western blot techniques with appropriate software

  • Time-course considerations: Design experiments to capture both immediate and long-term expression changes

  • Subcellular fractionation: Include fractionation steps if protein localization might change under different conditions

How can advanced proteomics approaches complement antibody-based detection of ybiU?

Complementary proteomics approaches include:

  • Quantitative MS/MS: Use SILAC or TMT labeling for precise quantification of ybiU across conditions

  • Protein-protein interaction mapping: Couple affinity purification with mass spectrometry (AP-MS) to identify interaction partners

  • Structural proteomics: Apply hydrogen-deuterium exchange mass spectrometry (HDX-MS) to study conformational changes

  • Targeted proteomics: Develop selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) assays for absolute quantification

  • In vivo crosslinking: Apply techniques like BioID or APEX proximity labeling to map the spatial environment of ybiU

What considerations should be made when integrating ybiU expression data with broader systems biology datasets?

For systems biology integration:

  • Data normalization: Ensure proper normalization across different experimental platforms

  • Multi-omics integration: Combine protein expression data with transcriptomics, metabolomics, and phenotypic data

  • Network analysis: Apply protein-protein interaction network analysis to position ybiU within cellular pathways

  • Comparative genomics: Integrate expression data with evolutionary conservation patterns across bacterial species

  • Computational modeling: Develop predictive models incorporating ybiU regulation and function

The integration of various datasets can provide deeper insights into the role of uncharacterized proteins like ybiU in bacterial physiology and stress responses .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.